A Single-Blind Study to Evaluate the Irritation Potential of Repeat Topical Applications of GSK1940029 Gel on the Intact Skin of Healthy Human Subjects and Acne Patients

Trial Profile

A Single-Blind Study to Evaluate the Irritation Potential of Repeat Topical Applications of GSK1940029 Gel on the Intact Skin of Healthy Human Subjects and Acne Patients

Completed
Phase of Trial: Phase I

Latest Information Update: 11 May 2017

At a glance

  • Drugs GSK 1940029 (Primary) ; Sodium lauril-sulfate
  • Indications Acne
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 11 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 24 Mar 2015 Planned End Date changed from 1 Oct 2014 to 1 Sep 2015 as reported by ClinicalTrials.gov record.
    • 24 Mar 2015 Planned primary completion date changed from 1 Oct 2014 to 1 Sep 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top